Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated IV Iron in Heart Failure
NCT01925703Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium ferric gluconate in iron deficiency anemia (IDA), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Serum Hemoglobin Concentration. Started Apr 2011; status: completed.
02
Drugs
sodium ferric gluconate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01925703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01925703.